| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Acamar Partners Acquisition (ACAMU) (u) | Goldman Sachs/ Deutsche Bank Securities | 30.00 | $10.00 | $10.00 | $300.00 | n.a. |
| Alector (ALEC) | Morgan Stanley/ BofA Merrill Lynch/ Cowen/ Barclays | $150.00 | n.a. | |||
| Anchiano Therapeutics (ANCN) | Oppenheimer | $35.00 | n.a. | |||
| Cirius Therapeutics (CSTX) | Citigroup/ Credit Suisse | $86.25 | n.a. | |||
| Exeter Finance (XTF) | Citigroup/ Wells Fargo Securities | $100.00 | n.a. | |||
| HeZhong International (Holding) Ltd. (HZ) | ViewTrade Securities | $5.75 | n.a. | |||
| Kaleido Biosciences (KLDO) | Goldman Sachs/ J.P. Morgan/ Morgan Stanley | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| u – unit offering | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Guardion Health Sciences (GHSI) | WallachBeth Capital | 2.17 | $4.00 | $4.00 | $8.70 | S/O |
| Hoth Therapeutics (HOTH) | Laidlaw & Company (UK) Ltd. | 2.25 | $5.50 | $6.50 | $13.50 | S/O |
| IMAC Holdings (IMAC) | Dawson James Securities/ Cuttone | 0.75 | $5.00 | $5.00 | $3.75 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Jan. 7, 2019 | Manager(s) | Offered | Raised | Price | 1/11/19 | Change |
| MMTEC (MTC) | WestPark Capital | 1.80 | $7.20 | $4.00 | $8.90 | 122.50% |
